Cleared Traditional

K250521 - NanoBone SBX Putty

Also marketed or referenced as:
NanoBone® QD

K250521 is the FDA 510(k) clearance for NanoBone SBX Putty by Biocomposites, Ltd.. It is a Class 2 Orthopedic device (product code MQV) cleared through the Traditional 510(k) pathway after a 45-day FDA review.

K250521 · Biocomposites, Ltd. · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2025
Decision
45d
Days
Class 2
Risk

K250521 is an FDA 510(k) clearance for the NanoBone® SBX Putty. Classified as Filler, Bone Void, Calcium Compound (product code MQV), Class II - Special Controls.

Submitted by Biocomposites, Ltd. (Keele, GB). The FDA issued a Cleared decision on April 7, 2025 after a review of 45 days - a notably fast clearance cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3045 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Biocomposites, Ltd. devices

Submission Details

510(k) Number K250521 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 21, 2025
Decision Date April 07, 2025
Days to Decision 45 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
77d faster than avg
Panel avg: 122d · This submission: 45d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MQV Filler, Bone Void, Calcium Compound
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3045
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Consultant

Bruder Consulting & Venture Group
Scott Bruder

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - MQV Filler, Bone Void, Calcium Compound

All 230
Devices cleared under the same product code (MQV) and FDA review panel - the closest regulatory comparables to K250521.
OsteoFlo HydroFiber
K243949 · SurGenTec, LLC · May 2025
MagnetOs MIS
K243474 · Kuros Biosciences B.V · May 2025
Synthecure Synthetic Calcium Sulfate
K250141 · Austin Medical Ventures, Inc. · May 2025
Porous Biologic Scaffold
K250556 · Ventris Medical · Mar 2025
BonVie+
K250346 · Elute, Inc. · Feb 2025
Moldable Bone Void Filler and Moldable Bone Void Filler + CCC
K241555 · Rti Surgical, Inc. · Feb 2025